Planning a Startup?

Premium

What’s the most important business lesson you’ve learned in your career? You don’t have to answer that — it’s a trick question. If you’re reading this article, you’re most likely an academic scientist who’s wondering what it would be like to start your own company. You’ve slaved over your scientific degrees, proven yourself in the lab, and hit upon a clever technology or concept that you might be able to parlay into the commercial world. But if you’re like most academic scientists, chances are good that you’ve never had any formal business training.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.